alprazolam

Generic: alprazolam

Labeler: actavis pharma, inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name alprazolam
Generic Name alprazolam
Labeler actavis pharma, inc.
Dosage Form TABLET, ORALLY DISINTEGRATING
Routes
ORAL
Active Ingredients

alprazolam 2 mg/1

Manufacturer
Actavis Pharma, Inc.

Identifiers & Regulatory

Product NDC 0228-4025
Product ID 0228-4025_38c5b407-25a1-48f5-960e-87ef637b644c
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA078561
DEA Schedule civ
Listing Expiration 2026-12-31
Marketing Start 2010-03-17

Pharmacologic Class

Established (EPC)
benzodiazepine [epc]
Chemical Structure
benzodiazepines [cs]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 02284025
Hyphenated Format 0228-4025

Supplemental Identifiers

RxCUI
485413 485414 485415 485416
UNII
YU55MQ3IZY
NUI
N0000175694 M0002356

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name alprazolam (source: ndc)
Generic Name alprazolam (source: ndc)
Application Number ANDA078561 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 2 mg/1
source: ndc
Packaging
  • 100 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (0228-4025-11)
source: ndc

Packages (1)

0228-4025-11 100 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (0228-4025-11)

Ingredients (1)

alprazolam (2 mg/1)

Linked Drug Pages (1)

Alprazolam ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "38c5b407-25a1-48f5-960e-87ef637b644c", "openfda": {"nui": ["N0000175694", "M0002356"], "unii": ["YU55MQ3IZY"], "rxcui": ["485413", "485414", "485415", "485416"], "spl_set_id": ["5ceed721-2e65-4c81-bd84-f110b1ac9d2e"], "pharm_class_cs": ["Benzodiazepines [CS]"], "pharm_class_epc": ["Benzodiazepine [EPC]"], "manufacturer_name": ["Actavis Pharma, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (0228-4025-11)", "package_ndc": "0228-4025-11", "marketing_start_date": "20100317"}], "brand_name": "Alprazolam", "product_id": "0228-4025_38c5b407-25a1-48f5-960e-87ef637b644c", "dosage_form": "TABLET, ORALLY DISINTEGRATING", "pharm_class": ["Benzodiazepine [EPC]", "Benzodiazepines [CS]"], "product_ndc": "0228-4025", "dea_schedule": "CIV", "generic_name": "Alprazolam", "labeler_name": "Actavis Pharma, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Alprazolam", "active_ingredients": [{"name": "ALPRAZOLAM", "strength": "2 mg/1"}], "application_number": "ANDA078561", "marketing_category": "ANDA", "marketing_start_date": "20100317", "listing_expiration_date": "20261231"}